FINWIRES · TerminalLIVE
FINWIRES

Otsuka Raises 2026 Earnings Forecast on Pharma Growth

By

Otsuka (TYO:4578) raised its 2026 attributable profit forecast to 355 billion yen from 265 billion yen previously estimated.

The healthcare conglomerate now expects basic earnings per share of 675.47 yen, up from 504.94 yen previously, according to a Tokyo bourse filing on Friday.

Revenue forecast for the year was lifted to 2.725 trillion yen from 2.520 trillion yen.

The upward revision was driven by continued growth in key drugs including Rexulti, Lonsurf and Voyxact, later-than-expected arrival of generic versions of Jynarque in the U.S. and Abilify Maintena in Europe and strong nutraceutical sales, as well as a weaker yen.

Related Articles

Asia

ASE Technology's Q2 Profit Shoots Up as Revenue Rises 27%

ASE Technology's (TPE:3711) attributable profit surged to NT$21.1 billion in the second quarter from NT$7.52 billion a year earlier.Diluted earnings per share rose to NT$4.61 from NT$1.70 a year earlier.Revenue climbed 27% year over year to NT$191.1 billion due to higher semiconductor assembly, testing and electronic manufacturing services sales. On a sequential basis, revenue increased 10%.Gross margin improved to 21% from 20% in the first quarter, while operating margin rose to 11% from 10%, it said.

TPE:3711
Asia

Fitch Affirms Sinochem at A, Stable Outlook

Fitch Ratings affirmed Sinochem International's (SHA:600500) long-term foreign-currency issuer default rating and senior unsecured rating at A-, with a stable outlook, the ratings firm said Thursday.The new ratings reflected the state-owned firm's parent, Sinochem Holdings Corporation, which was rated with "Low" legal, "Medium" strategic, and "High" operational incentives to support Sinochem.The ratings firm decided to withdraw the ratings due to commercial reasons.

SHA:600500
Asia

Cinda Securities H1 Profit Up 7%, Revenue Rises 20%

Cinda Securities (SHA:601059) posted first-half attributable net profit of 1.10 billion yuan, up 7.2% from 1.02 billion yuan the previous year.Earnings per share were unchanged at 0.30 yuan, according to a filing with the Shanghai bourseOperating revenue climbed 20% year over year to 2.44 billion yuan from 2.04 billion yuan.Shares of the brokerage were down 1% in recent trade.

SHA:601059